Qilibri has been acquired by SP2L (NaturAvignon Laboratory)
The owners of Qilibri, which include the co-founders, Day One Entrepreneurs & Partners, Pléiade Venture and Financière Saint-James, and business angels, have sold the company to SP2L (NaturAvignon Laboratory).
Qilibri is a French digital-native brand founded in 2019 by two experienced entrepreneurs, offering a holistic approach to weight loss through healthy pre-cooked meals delivery, professional dietary assistance and sports training. Qilibri uses algorithms to determine customers’ needs in order to maximize weight loss and lasting results, compared with standard offers. Qilibri’s objective is to redesign weight loss with a 360° offer based on a 100% customized program, which includes a qualitative nutrition offer designed by expert dieticians and a complete service offer via weekly professional dietary coaching, access to an online community and sport training, in partnership with a leading fitness club operator. Qilibri’s innovative, fully customized and efficient offer has enabled the company to quickly develop a community of approximately 200,000 people. Today, Qilibri is a brand recognized for its ability to leverage customers’ data, enabling to build a personalized and qualitative relationship throughout the program.
Founded in 2003, Groupe SP2L (Laboratoire NaturAvignon) offers safe, effective dietary supplements, health products and professional support to help seniors improve their health. Groupe SP2L comprises two brands: Laboratoire NaturAvignon, an emblematic brand in nutraceuticals for 20 years, and Blanche Bresson Institut, a digital brand of natural and organic food supplements.
Oaklins’ team in France acted as sell-side M&A advisor in the transaction.
联系交易团队
相关交易
Bayer AG has entered into a takeover agreement with Cara Care
Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.
更多信息Grupo Veta 2017 S.L. has been acquired by MSA Mizar
The Franco-Belgian fund Kartesia has sold Grupo Veta 2017 S.L. to the Italian group MSA Mizar. Kartesia, the main shareholder of Veta+ together with its founding partner, has sold 100% of the capital. For MSA Mizar, this transaction represents the consolidation of its presence in Spain, the entry into the multi-risk claims management market and the opportunity to apply Veta+’s expertise to other European markets.
更多信息AYANDA CAPITAL has added a new investor to its shareholding
A new investor, Thierry Jacobs, has joined AYANDA CAPITAL S.L.’s shareholding with a minority stake.
更多信息